Sheldon Inwentash shares his current investment philosophy, focusing on global debt and currency devaluation along with his appetite for digital and other disruptive technologies.
Mr. Inwentash has more than 30 years of investing experience and has been instrumental in raising $15 billion for his portfolio companies over the last 15 years. He co-founded Visible Genetics, the first commercial pharmacogenomics company, in 1994 and exited in 2001 to Bayer. Through two decades leading Pinetree Capital, Mr. Inwentash created significant shareholder value through early investments in Queenston Mining (acquired by Osisko Mining Corp. for $550-million), Aurelian Resources (acquired by Kinross for $1.2-billion) and Gold Eagle Mines (acquired by Goldcorp for $1.5-billion) to name a few.
Tags: artificial intelligence, blockchain, CSE, Digital, Disruptive companies, disruptive technologies, esports, gold, IOT, shrooms, small cap, small cap stocks, stocks